Since July 2020, remdesivir has been conditionally approved in Europe for the treatment of coronavirus disease (COVID-19) in adults and adolescents aged 12 years and older with pneumonia who require supplemental oxygen but no invasive ventilation. In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated […]
Home »
Case report: Remdesivir induced dangerously low heart rate in a COVID-19 patient
After beginning treatment with remdesivir for COVID-19, a patient experienced significant bradycardia, or low heart rate. Her physicians used a dopamine infusion to stabilize her through the five-day course of remdesivir treatment, and her cardiac condition resolved itself at the end of the treatment. The case is discussed in Heart Rhythm Case Reports. “Remdesivir has […]
India bans export of COVID-19 treatment drug remdesivir
India on Sunday banned the export of remdesivir as infections soared to a new daily high and hospitals grappled with increasing demand for the coronavirus treatment drug. The vast nation has experienced a sharp rise in cases in recent weeks, adding 152,000 new cases on Sunday to take the toll to 13.3 million infections. The […]
FDA issues EUA to baricitinib plus remdesivir for COVID-19
(HealthDay)—Emergency use authorization was issued for baricitinib in combination with remdesivir for hospitalized patients with COVID-19, the U.S. Food and Drug Administration announced Thursday. The EUA for the combination treatment applies to hospitalized patients ages 2 years and older with suspected or laboratory-confirmed COVID-19 who require supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation. […]
WHO advises against remdesivir for coronavirus treatment
The anti-viral drug remdesivir should not be used to treat COVID-19 patients no matter how severe their illness as it has “no important effect” on survival chances, the World Health Organization said Friday. Denting hopes in one of the few treatments that had shown some initial promise in severe patients, a WHO Guideline Development Group […]
Coronavirus: Study hints antibody drug may cut Covid-19 hospitalizations
A drug company says that partial results from a study testing an antibody drug give hints that it may help keep mild to moderately ill COVID-19 patients from needing to be hospitalized, a goal no current coronavirus medicine has been able to meet. Eli Lilly announced the results Wednesday in a press release, but they […]
Gilead says it has ramped up production of remdesivir by 50-fold
Gilead ramps up production of its coronavirus drug remdesivir 50-FOLD and promises 12.5 million doses by year-end Gilead Sciences Inc says it has ramped up production its antiviral, remdesivir, by 50-fold since January The drug is the only one approved in the US to treat severely ill coronavirus patients after it was shown to reduce the […]
Coronavirus update: New antiviral drug gaining traction which could help with COVID-19
The fast-evolving COVID-19 pandemic is posing unusual and often frustrating challenges in the search for new drugs and vaccines, forcing researchers to rework or sometimes even scrap clinical trials as the science becomes null in void and with current lockdowns still taking place in most parts of the world, study subjects are proving difficult to […]